Subscriptions received in separate tranche of previously announced directed share issue 2023-11-062023-11-03
Genetic Analysis announces placement of directed share issue of appr. NOK 10 mill, intention to conduct subsequent offering to shareholders, non-binding letter of intent for further investment as well as updated milestones 2023-11-022023-11-02 GA private placement letter of intent milestones
Genetic Analysis: Launch of GA-map® Discovery – A microbiome profiling offering for Research Customers 2023-10-252023-10-24 GA-map new product Discovery launch
Genetic Analysis AS ramps up its market presence for the GA-map® microbiome testing in the US 2023-08-25